<DOC>
	<DOC>NCT01861613</DOC>
	<brief_summary>At present, children less than 15 y of age have been regarded as a key group for hepatitis B immunization in China. However, there is not yet special immunization strategy for population above 15 y of age. In this study, we investigated the seroprevalence of hepatitis B and immune response to HB vaccine among Chinese college students to uncover the need on universal mass vaccination or booster immunization only for students with HBV vaccination history against hepatitis B in Chinese college students to inform decision making.</brief_summary>
	<brief_title>Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male and female freshmen in one college in Liuzhou city of Guangxi Zhuang Autonomous Region Exclusion Criteria for vaccination study: acute illness immunocompromised conditions renal insufficiency pregnancy allergic history to HB vaccine or yeast positive for any of HBsAg, antiHBs or antiHBc</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>